Introduction
Herpes simplex is usually diagnosed through a combination of clinical observation and laboratory testing. The condition is caused by herpes simplex virus type 1 (HSV-1) or type 2 (HSV-2), both of which infect epithelial cells and establish lifelong latency in sensory nerve ganglia. Because the virus can remain dormant and reactivate intermittently, diagnosis is not always straightforward. Some people present with classic painful vesicles or ulcers, while others have mild, atypical, or no visible lesions at all. Accurate diagnosis matters because it helps distinguish herpes from other infections, guides counseling about transmission and recurrence, and supports appropriate treatment, particularly when lesions are new, severe, or occurring in pregnancy or immunocompromised patients.
Recognizing Possible Signs of the Condition
Medical professionals often begin with the visible pattern of disease. Herpes simplex commonly causes grouped vesicles on a red base that rupture into shallow, painful erosions or ulcers. The lesions may appear on the lips, mouth, genitals, buttocks, thighs, or nearby skin depending on the site of infection. A primary episode may be accompanied by fever, malaise, tender lymph nodes, and significant local pain. Recurrent outbreaks are often shorter and less intense, but they can still produce burning, tingling, itching, or pain before lesions appear. This prodromal sensation reflects reactivation of virus from a sensory ganglion and spread along the nerve to the skin or mucosa.
Clinicians also consider lesion behavior. Herpetic lesions tend to be clustered and may recur in the same general area because the virus follows the same neuronal pathway. Oral herpes may present as cold sores at the vermilion border of the lip, while genital herpes often causes painful ulcers, dysuria, or fissures. However, symptoms alone do not confirm the diagnosis. Similar-appearing lesions can be caused by other infections, inflammatory skin disorders, trauma, or aphthous ulceration, so laboratory confirmation is often needed.
Medical History and Physical Examination
The diagnostic process begins with a focused history. A clinician will ask when the symptoms started, whether there was pain or tingling before the lesions, how the lesions evolved, and whether similar episodes have occurred before. They may ask about oral-genital contact, sexual exposure, recent fever or illness, immune suppression, pregnancy, and known contact with someone who has herpes. In recurrent disease, the timing of outbreaks can be important because stress, illness, ultraviolet exposure, menstrual cycles, and local trauma can trigger viral reactivation.
During the physical examination, the clinician looks for the morphology and distribution of lesions. The size, number, stage, and arrangement of vesicles or ulcers can suggest herpes, especially if the lesions are grouped and uniform in appearance. Examination may include the mouth, lips, genital area, perianal region, and adjacent skin. If lesions are present, the base of a fresh vesicle or ulcer is often the best site for sampling. The examiner may also look for tender lymph nodes, signs of secondary bacterial infection, or more extensive involvement suggesting a severe first episode or immunocompromise.
In many cases, the appearance is suggestive but not definitive. Herpes simplex can be subtle early in the course, and lesions may have already crusted or healed by the time of examination. That is why clinicians rely on both clinical context and testing, rather than appearance alone.
Diagnostic Tests Used for Herpes simplex
The most useful tests are laboratory tests performed on material from a lesion or, in some circumstances, on blood samples. The preferred confirmatory method is polymerase chain reaction, or PCR, which detects viral DNA in a swab from the base of a lesion. PCR is highly sensitive and specific, and it can distinguish HSV-1 from HSV-2. This distinction is clinically useful because the two types differ in typical site, recurrence frequency, and epidemiology. PCR can still detect herpes when viral quantity is low, making it especially valuable for lesions that are early, healing, or atypical.
Viral culture is another laboratory test. A swab from a fresh vesicle or ulcer is placed into cell culture to see whether the virus grows. Culture has historically been widely used, and a positive result confirms infection and can identify viral type. However, it is less sensitive than PCR, particularly when lesions are older, partially healed, or caused by recurrent disease with low viral shedding. For this reason, a negative culture does not reliably exclude herpes if clinical suspicion remains high.
Direct fluorescent antibody testing or antigen detection may also be used in some settings. These tests look for viral proteins in lesion material. They are faster than culture but generally less sensitive than PCR. They can be useful where molecular testing is not available, although they are less commonly the first choice in many healthcare systems.
Blood tests for herpes simplex antibodies, usually type-specific IgG tests, can help determine whether a person has been exposed to HSV-1 or HSV-2 in the past. These tests do not diagnose an active lesion by themselves, because antibodies may remain positive long after infection and may not tell whether current symptoms are caused by herpes. They are most helpful when symptoms are absent or when a patient has recurrent, unexplained episodes and lesion-based testing is not possible. Early after infection, antibody tests may be negative because the immune system has not yet produced detectable antibodies, so a repeat test later may be needed if recent acquisition is suspected.
Imaging tests are not used routinely to diagnose uncomplicated herpes simplex. However, imaging may become relevant if there is concern for complications such as encephalitis, disseminated infection, or involvement of deeper structures. For example, magnetic resonance imaging of the brain may support the evaluation of suspected HSV encephalitis, which can cause fever, confusion, seizures, or focal neurologic deficits. Imaging does not confirm the viral diagnosis by itself, but it can show inflammation or tissue injury that guides urgent treatment and further testing, such as cerebrospinal fluid PCR.
Functional tests are also not standard for ordinary mucocutaneous herpes, but neurologic or sensory findings may be assessed when complications are suspected. In a patient with possible herpes-related central nervous system disease, clinicians may evaluate mental status, speech, coordination, reflexes, or seizure activity as part of functional assessment. These findings help determine whether the infection has extended beyond the skin or mucosa.
Tissue examination is occasionally used when the diagnosis is unclear. A biopsy of a lesion may show characteristic viral cytopathic changes, including multinucleated giant cells, nuclear molding, and chromatin margination. Histologic findings can support the diagnosis, especially when the lesion is unusual or when cancer, autoimmune disease, or another chronic ulcerative disorder must be ruled out. Biopsy is not usually needed for classic lesions but can be valuable when standard tests are negative or when the presentation is persistent or atypical.
Interpreting Diagnostic Results
Doctors interpret test results in the context of timing, lesion stage, and clinical appearance. A positive PCR from a lesion is strong evidence of active herpes simplex infection, and type-specific results help identify whether HSV-1 or HSV-2 is involved. A positive culture is also confirmatory, though a negative culture cannot exclude disease, especially if the lesion is older or the sample was collected late. This is because viral shedding drops as the lesion heals and the amount of recoverable virus decreases.
Serology requires more caution. A positive HSV-1 or HSV-2 IgG test indicates past exposure, not necessarily the cause of the current symptoms. If a patient has a new lesion and the antibody test is negative, this may mean the person has not yet seroconverted or that the lesion is not caused by herpes. In some cases, clinicians repeat serology several weeks later to look for evidence of new infection. Results are most useful when combined with lesion testing and the patient’s history.
When testing is negative but suspicion remains high, clinicians may re-evaluate the sample quality, consider whether the lesion was sampled too late, and assess for alternate diagnoses. No single test is perfect in every situation, so diagnosis often depends on concordance between symptoms, physical findings, and laboratory evidence.
Conditions That May Need to Be Distinguished
Several conditions can mimic herpes simplex. Aphthous ulcers may resemble oral herpes but usually occur on non-keratinized mucosa and are not typically preceded by vesicles. Impetigo can cause crusted skin lesions, especially around the mouth or nose, but it is usually more superficial and bacterial in origin. Varicella-zoster virus can cause grouped vesicles and ulcers, yet the distribution often follows a dermatomal pattern and is more likely to be unilateral. Syphilis may produce genital or oral ulcers, but these are classically painless and require different serologic testing.
Other distinctions include chancroid, which can cause painful genital ulcers with a softer base and significant inflammation, and allergic or irritant contact dermatitis, which may produce erosions or burning but lacks viral cytopathic features. Fixed drug eruption can recur at the same site and may blister or erode, making it another herpes-like mimic. In the mouth, traumatic ulcers, Behcet disease, and erythema multiforme can also enter the differential diagnosis. The clinician separates these conditions by evaluating lesion shape, pain pattern, recurrence, associated symptoms, exposure history, and laboratory results.
Factors That Influence Diagnosis
Several factors affect how herpes simplex is diagnosed. Age matters because neonates, children, and adults may present differently. In infants, HSV can cause nonspecific signs such as lethargy, fever, poor feeding, or vesicular rash, and diagnosis often requires urgent testing because disease can become systemic quickly. In older adults, lesions may be less typical, especially if immune function is reduced.
Severity and immune status also matter. People with HIV infection, transplant recipients, chemotherapy exposure, or other causes of immunosuppression may have larger, more persistent, or unusual lesions, and they may shed virus longer. In these patients, clinicians may use more aggressive testing and maintain a broader differential diagnosis. Pregnancy introduces additional urgency because identifying primary genital herpes near delivery can affect neonatal risk and obstetric management.
The stage of the lesion is a major practical factor. Fresh vesicles are best for swab-based testing, while crusted or healing lesions may yield false-negative results, especially with culture. Delayed presentation often makes diagnosis more difficult. Prior antiviral treatment can also reduce viral load and decrease the likelihood of recovering the virus from a lesion.
Conclusion
Herpes simplex is diagnosed by combining the clinical picture with targeted testing. The process starts with recognizing characteristic lesions, pain patterns, and recurrence history, then confirming the finding with laboratory methods such as PCR, culture, antigen testing, or type-specific serology. Imaging, functional assessment, and tissue examination are reserved for complicated, severe, or atypical cases. Because herpes can resemble other ulcerative or vesicular disorders and because lesion appearance changes over time, accurate diagnosis depends on careful sample collection and thoughtful interpretation of results. When evaluated in this structured way, herpes simplex can usually be identified with a high degree of confidence.